Global and United States Biopharmaceutical CMO and CRO Market Size, Status and Forecast 2021-2027

SKU ID :QYR-19208159 | Published Date: 23-Sep-2021 | No. of pages: 105
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Contract Manufacturing 1.2.3 Contract Research 1.3 Market by Application 1.3.1 Global Biopharmaceutical CMO and CRO Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Biologics Manuefacturing 1.3.3 Biosimilars Manuefacturing 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Biopharmaceutical CMO and CRO Market Perspective (2016-2027) 2.2 Biopharmaceutical CMO and CRO Growth Trends by Regions 2.2.1 Biopharmaceutical CMO and CRO Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Biopharmaceutical CMO and CRO Historic Market Share by Regions (2016-2021) 2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Regions (2022-2027) 2.3 Biopharmaceutical CMO and CRO Industry Dynamic 2.3.1 Biopharmaceutical CMO and CRO Market Trends 2.3.2 Biopharmaceutical CMO and CRO Market Drivers 2.3.3 Biopharmaceutical CMO and CRO Market Challenges 2.3.4 Biopharmaceutical CMO and CRO Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue 3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2016-2021) 3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2016-2021) 3.2 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Biopharmaceutical CMO and CRO Revenue 3.4 Global Biopharmaceutical CMO and CRO Market Concentration Ratio 3.4.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2020 3.5 Biopharmaceutical CMO and CRO Key Players Head office and Area Served 3.6 Key Players Biopharmaceutical CMO and CRO Product Solution and Service 3.7 Date of Enter into Biopharmaceutical CMO and CRO Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biopharmaceutical CMO and CRO Breakdown Data by Type 4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2016-2021) 4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2022-2027) 5 Biopharmaceutical CMO and CRO Breakdown Data by Application 5.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Application (2016-2021) 5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Biopharmaceutical CMO and CRO Market Size (2016-2027) 6.2 North America Biopharmaceutical CMO and CRO Market Size by Type 6.2.1 North America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) 6.2.2 North America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) 6.2.3 North America Biopharmaceutical CMO and CRO Market Size by Type (2016-2027) 6.3 North America Biopharmaceutical CMO and CRO Market Size by Application 6.3.1 North America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) 6.3.2 North America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) 6.3.3 North America Biopharmaceutical CMO and CRO Market Size by Application (2016-2027) 6.4 North America Biopharmaceutical CMO and CRO Market Size by Country 6.4.1 North America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) 6.4.2 North America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Biopharmaceutical CMO and CRO Market Size (2016-2027) 7.2 Europe Biopharmaceutical CMO and CRO Market Size by Type 7.2.1 Europe Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) 7.2.2 Europe Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) 7.2.3 Europe Biopharmaceutical CMO and CRO Market Size by Type (2016-2027) 7.3 Europe Biopharmaceutical CMO and CRO Market Size by Application 7.3.1 Europe Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) 7.3.2 Europe Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) 7.3.3 Europe Biopharmaceutical CMO and CRO Market Size by Application (2016-2027) 7.4 Europe Biopharmaceutical CMO and CRO Market Size by Country 7.4.1 Europe Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) 7.4.2 Europe Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size (2016-2027) 8.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type 8.2.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2016-2027) 8.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application 8.3.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2016-2027) 8.4 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region 8.4.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Biopharmaceutical CMO and CRO Market Size (2016-2027) 9.2 Latin America Biopharmaceutical CMO and CRO Market Size by Type 9.2.1 Latin America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) 9.2.2 Latin America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) 9.2.3 Latin America Biopharmaceutical CMO and CRO Market Size by Type (2016-2027) 9.3 Latin America Biopharmaceutical CMO and CRO Market Size by Application 9.3.1 Latin America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) 9.3.2 Latin America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) 9.3.3 Latin America Biopharmaceutical CMO and CRO Market Size by Application (2016-2027) 9.4 Latin America Biopharmaceutical CMO and CRO Market Size by Country 9.4.1 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) 9.4.2 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size (2016-2027) 10.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type 10.2.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2016-2027) 10.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application 10.3.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2016-2027) 10.4 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country 10.4.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AGC Biologics 11.1.1 AGC Biologics Company Details 11.1.2 AGC Biologics Business Overview 11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction 11.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.1.5 AGC Biologics Recent Development 11.2 Boehringer Ingelheim International GmbH 11.2.1 Boehringer Ingelheim International GmbH Company Details 11.2.2 Boehringer Ingelheim International GmbH Business Overview 11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction 11.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.2.5 Boehringer Ingelheim International GmbH Recent Development 11.3 FUJIFILM Diosynth Biotechnologies 11.3.1 FUJIFILM Diosynth Biotechnologies Company Details 11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview 11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction 11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development 11.4 Inno Bio Ventures Sdn Bhd 11.4.1 Inno Bio Ventures Sdn Bhd Company Details 11.4.2 Inno Bio Ventures Sdn Bhd Business Overview 11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction 11.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.4.5 Inno Bio Ventures Sdn Bhd Recent Development 11.5 JRS PHARMA 11.5.1 JRS PHARMA Company Details 11.5.2 JRS PHARMA Business Overview 11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction 11.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.5.5 JRS PHARMA Recent Development 11.6 Lonza 11.6.1 Lonza Company Details 11.6.2 Lonza Business Overview 11.6.3 Lonza Biopharmaceutical CMO and CRO Introduction 11.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.6.5 Lonza Recent Development 11.7 PRA Health Sciences, Inc. 11.7.1 PRA Health Sciences, Inc. Company Details 11.7.2 PRA Health Sciences, Inc. Business Overview 11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction 11.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.7.5 PRA Health Sciences, Inc. Recent Development 11.8 ProBioGen AG 11.8.1 ProBioGen AG Company Details 11.8.2 ProBioGen AG Business Overview 11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction 11.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.8.5 ProBioGen AG Recent Development 11.9 Rentschler Biopharma SE 11.9.1 Rentschler Biopharma SE Company Details 11.9.2 Rentschler Biopharma SE Business Overview 11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction 11.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.9.5 Rentschler Biopharma SE Recent Development 11.10 Samsung BioLogics 11.10.1 Samsung BioLogics Company Details 11.10.2 Samsung BioLogics Business Overview 11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction 11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) 11.10.5 Samsung BioLogics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Contract Manufacturing Table 3. Key Players of Contract Research Table 4. Global Biopharmaceutical CMO and CRO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Biopharmaceutical CMO and CRO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Biopharmaceutical CMO and CRO Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Biopharmaceutical CMO and CRO Market Share by Regions (2016-2021) Table 8. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Biopharmaceutical CMO and CRO Market Share by Regions (2022-2027) Table 10. Biopharmaceutical CMO and CRO Market Trends Table 11. Biopharmaceutical CMO and CRO Market Drivers Table 12. Biopharmaceutical CMO and CRO Market Challenges Table 13. Biopharmaceutical CMO and CRO Market Restraints Table 14. Global Biopharmaceutical CMO and CRO Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Biopharmaceutical CMO and CRO Market Share by Players (2016-2021) Table 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO and CRO as of 2020) Table 17. Ranking of Global Top Biopharmaceutical CMO and CRO Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO and CRO Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Biopharmaceutical CMO and CRO Product Solution and Service Table 21. Date of Enter into Biopharmaceutical CMO and CRO Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million) Table 24. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2016-2021) Table 25. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Biopharmaceutical CMO and CRO Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2016-2021) Table 29. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million) Table 32. North America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million) Table 34. North America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2022-2027) & (US$ Million) Table 61. AGC Biologics Company Details Table 62. AGC Biologics Business Overview Table 63. AGC Biologics Biopharmaceutical CMO and CRO Product Table 64. AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 65. AGC Biologics Recent Development Table 66. Boehringer Ingelheim International GmbH Company Details Table 67. Boehringer Ingelheim International GmbH Business Overview Table 68. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Table 69. Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 70. Boehringer Ingelheim International GmbH Recent Development Table 71. FUJIFILM Diosynth Biotechnologies Company Details Table 72. FUJIFILM Diosynth Biotechnologies Business Overview Table 73. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Table 74. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 75. FUJIFILM Diosynth Biotechnologies Recent Development Table 76. Inno Bio Ventures Sdn Bhd Company Details Table 77. Inno Bio Ventures Sdn Bhd Business Overview Table 78. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Table 79. Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 80. Inno Bio Ventures Sdn Bhd Recent Development Table 81. JRS PHARMA Company Details Table 82. JRS PHARMA Business Overview Table 83. JRS PHARMA Biopharmaceutical CMO and CRO Product Table 84. JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 85. JRS PHARMA Recent Development Table 86. Lonza Company Details Table 87. Lonza Business Overview Table 88. Lonza Biopharmaceutical CMO and CRO Product Table 89. Lonza Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 90. Lonza Recent Development Table 91. PRA Health Sciences, Inc. Company Details Table 92. PRA Health Sciences, Inc. Business Overview Table 93. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Table 94. PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 95. PRA Health Sciences, Inc. Recent Development Table 96. ProBioGen AG Company Details Table 97. ProBioGen AG Business Overview Table 98. ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 99. ProBioGen AG Recent Development Table 100. Rentschler Biopharma SE Company Details Table 101. Rentschler Biopharma SE Business Overview Table 102. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Table 103. Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 104. Rentschler Biopharma SE Recent Development Table 105. Samsung BioLogics Company Details Table 106. Samsung BioLogics Business Overview Table 107. Samsung BioLogics Biopharmaceutical CMO and CRO Product Table 108. Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2016-2021) & (US$ Million) Table 109. Samsung BioLogics Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Biopharmaceutical CMO and CRO Market Share by Type: 2020 VS 2027 Figure 2. Contract Manufacturing Features Figure 3. Contract Research Features Figure 4. Global Biopharmaceutical CMO and CRO Market Share by Application: 2020 VS 2027 Figure 5. Biologics Manuefacturing Case Studies Figure 6. Biosimilars Manuefacturing Case Studies Figure 7. Other Case Studies Figure 8. Biopharmaceutical CMO and CRO Report Years Considered Figure 9. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Biopharmaceutical CMO and CRO Market Share by Regions: 2020 VS 2027 Figure 12. Global Biopharmaceutical CMO and CRO Market Share by Regions (2022-2027) Figure 13. Global Biopharmaceutical CMO and CRO Market Share by Players in 2020 Figure 14. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO and CRO as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO and CRO Revenue in 2020 Figure 16. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2016-2021) Figure 17. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2022-2027) Figure 18. North America Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Biopharmaceutical CMO and CRO Market Share by Type (2016-2027) Figure 20. North America Biopharmaceutical CMO and CRO Market Share by Application (2016-2027) Figure 21. North America Biopharmaceutical CMO and CRO Market Share by Country (2016-2027) Figure 22. United States Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Biopharmaceutical CMO and CRO Market Share by Type (2016-2027) Figure 26. Europe Biopharmaceutical CMO and CRO Market Share by Application (2016-2027) Figure 27. Europe Biopharmaceutical CMO and CRO Market Share by Country (2016-2027) Figure 28. Germany Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Type (2016-2027) Figure 36. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Application (2016-2027) Figure 37. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Region (2016-2027) Figure 38. China Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Biopharmaceutical CMO and CRO Market Share by Type (2016-2027) Figure 46. Latin America Biopharmaceutical CMO and CRO Market Share by Application (2016-2027) Figure 47. Latin America Biopharmaceutical CMO and CRO Market Share by Country (2016-2027) Figure 48. Mexico Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Type (2016-2027) Figure 52. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Application (2016-2027) Figure 53. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Country (2016-2027) Figure 54. Turkey Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Biopharmaceutical CMO and CRO Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 58. Boehringer Ingelheim International GmbH Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 59. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 60. Inno Bio Ventures Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 61. JRS PHARMA Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 62. Lonza Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 63. PRA Health Sciences, Inc. Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 64. ProBioGen AG Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 65. Rentschler Biopharma SE Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 66. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
AGC Biologics Boehringer Ingelheim International GmbH FUJIFILM Diosynth Biotechnologies Inno Bio Ventures Sdn Bhd JRS PHARMA Lonza PRA Health Sciences, Inc. ProBioGen AG Rentschler Biopharma SE Samsung BioLogics
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients